Strong Q1 margins and unchanged guidance support momentum, while medical softness and oil-price mitigation remain key watchpoints.
| Quarter | Q1 FY26 |
|---|---|
| Length | 55 minutes |
| EPS | $1.32 |
| EPS consensus | $1.20 |
| Revenue | $3.4B |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY26 · Q4 FY25 · Q3 FY25 · Q2 FY25
All HSIC earnings · Back to HSIC overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.